BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

892 related articles for article (PubMed ID: 17678629)

  • 1. Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease.
    Raffetto JD; Khalil RA
    Biochem Pharmacol; 2008 Jan; 75(2):346-59. PubMed ID: 17678629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix Metalloproteinase Inhibitors as Investigational and Therapeutic Tools in Unrestrained Tissue Remodeling and Pathological Disorders.
    Liu J; Khalil RA
    Prog Mol Biol Transl Sci; 2017; 148():355-420. PubMed ID: 28662828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease.
    Benjamin MM; Khalil RA
    Exp Suppl; 2012; 103():209-79. PubMed ID: 22642194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinases as potential targets in the venous dilation associated with varicose veins.
    Kucukguven A; Khalil RA
    Curr Drug Targets; 2013 Mar; 14(3):287-324. PubMed ID: 23316963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease.
    Wang X; Khalil RA
    Adv Pharmacol; 2018; 81():241-330. PubMed ID: 29310800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation and involvement of matrix metalloproteinases in vascular diseases.
    Amin M; Pushpakumar S; Muradashvili N; Kundu S; Tyagi SC; Sen U
    Front Biosci (Landmark Ed); 2016 Jan; 21(1):89-118. PubMed ID: 26709763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinases and their tissue inhibitors in hypertension-related pregnancy complications.
    Karthikeyan VJ; Lane DA; Beevers DG; Lip GY; Blann AD
    J Hum Hypertens; 2013 Feb; 27(2):72-8. PubMed ID: 22418748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix Metalloproteinases in Remodeling of Lower Extremity Veins and Chronic Venous Disease.
    Chen Y; Peng W; Raffetto JD; Khalil RA
    Prog Mol Biol Transl Sci; 2017; 147():267-299. PubMed ID: 28413031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix Metalloproteinases as Regulators of Vein Structure and Function: Implications in Chronic Venous Disease.
    MacColl E; Khalil RA
    J Pharmacol Exp Ther; 2015 Dec; 355(3):410-28. PubMed ID: 26319699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinases in vascular physiology and disease.
    Siefert SA; Sarkar R
    Vascular; 2012 Aug; 20(4):210-6. PubMed ID: 22896663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinases: their potential role in the pathogenesis of diabetic nephropathy.
    Thrailkill KM; Clay Bunn R; Fowlkes JL
    Endocrine; 2009 Feb; 35(1):1-10. PubMed ID: 18972226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinases: contribution to pathogenesis, diagnosis, surveillance and treatment of abdominal aortic aneurysms.
    Kadoglou NP; Liapis CD
    Curr Med Res Opin; 2004 Apr; 20(4):419-32. PubMed ID: 15119978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinases, inflammation and atherosclerosis: therapeutic perspectives.
    Beaudeux JL; Giral P; Bruckert E; Foglietti MJ; Chapman MJ
    Clin Chem Lab Med; 2004 Feb; 42(2):121-31. PubMed ID: 15061349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinases (MMPs) in health and disease: an overview.
    Malemud CJ
    Front Biosci; 2006 May; 11():1696-701. PubMed ID: 16368548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical and Biological Attributes of Matrix Metalloproteinases.
    Cui N; Hu M; Khalil RA
    Prog Mol Biol Transl Sci; 2017; 147():1-73. PubMed ID: 28413025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinases contribute to endotoxin and interleukin-1beta induced vascular dysfunction.
    Lalu MM; Cena J; Chowdhury R; Lam A; Schulz R
    Br J Pharmacol; 2006 Sep; 149(1):31-42. PubMed ID: 16880766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of metalloproteinases in modification of extracellular matrix in invasive tumor growth, metastasis and angiogenesis].
    Fink K; Boratyński J
    Postepy Hig Med Dosw (Online); 2012 Sep; 66():609-28. PubMed ID: 23001203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix Metalloproteinases in Normal Pregnancy and Preeclampsia.
    Chen J; Khalil RA
    Prog Mol Biol Transl Sci; 2017; 148():87-165. PubMed ID: 28662830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases.
    Cabral-Pacheco GA; Garza-Veloz I; Castruita-De la Rosa C; Ramirez-Acuña JM; Perez-Romero BA; Guerrero-Rodriguez JF; Martinez-Avila N; Martinez-Fierro ML
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33419373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role of matrix metalloproteinases and their tissue inhibitors in angiogenesis].
    Bogaczewicz J; Dudek W; Zubilewicz T; Wroński J; Przywara S; Chodorowska G; Krasowska D
    Pol Merkur Lekarski; 2006 Jul; 21(121):80-5. PubMed ID: 17007300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.